Seroprevalence of HIV, Hepatitis B and C Viruses, and Treponema Pallidum among Blood Donors Attending the Garoua Regional Hospital Blood Bank, North Cameroon, a Cross-Sectional Study
Main Article Content
Abstract
Background. Human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C virus (HCV) are transfusion-transmittable infections (TTI). They currently constitute a major public health problem in Cameroon, like in other developing countries. Little is known about the seroprevalence of HIV, HBV, HCV, and syphilis among blood donors in northern region Cameroun. This study aims at filling the gap on the unknown sero-prevalence of those markers in blood donors.
Methods. We conducted a cross-sectional study from June 04, to July 08, 2022 at the Garoua Regional Hospital Blood Bank (GRHBB). A total of 201donors were consecutively included and data on donor’s sociodemographic characteristics were obtained by the national program’s questionnaire. Serum samples from blood donors were tested using sensitive third generation Rapid diagnostic test (RDT) for presence of Hepatits B surface antigens (HBsAg), and antibodies to human immunodeficiency (HIV-1/2), Hepatits C (HCV) and Treponema pallidum; and quantitative enzyme-linked immunosorbent assays (ELISA) served for confirmation. Data were collected and entered into an Excel sheet and then exported to SPSS version 20.0 for analysis.
Results. A total of 201 blood donors were identified and the sex ratio (male/female) was 7/1, with a mean age of 32.12 ± 8.4 years (range: 19 to 57 years). Of all blood donors, 35/201 (17.4%) were infested by at least one of the four TTIs. Among blood donors, HIV, HBV, HCV and syphilis were 5 (2.5%); 26 (12.9%); 1 (0.5%) and 5 (2.5%), respectively. Co-infection with HIV-Syphilis was 1 (0.5%); and HBV-HCV 1 (0.5%).
Conclusions. This study has revealed the high prevalence of TTIs in blood donors who attended the Garoua Regional Hospital Blood Bank, identifying Hepatitis B as the greatest threat to blood safety in the North Region of Cameroon.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. World Health Organization, « Model List of Essential Medicines for Children 7th List ». World Health Organization, 2019.
II. A. Loua, J. Nikiema, O. Kasilo, et C. T. Tagny, « Blood safety and availability in the WHO African region », Glob Surg, vol. 4, no 4, 2018, doi: 10.15761/GOS.1000189.
III. C. T. Tagny et al., « Updated characteristics of blood services, donors and blood products in 11 French‐speaking African countries », Vox Sang, vol. 113, no 7, p. 647‑656, oct. 2018, doi: 10.1111/vox.12702.
IV. B. Custer et al., « Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop: BLOOD AVAILABILITY AND TRANSFUSION SAFETY IN LMICs », Transfusion, vol. 58, no 5, p. 1307‑1317, mai 2018, doi: 10.1111/trf.14598.
V. R. Idro et J. Aloyo, « Manifestations, Quality of Emergency Care and Outcome of Severe Malaria in Mulago Hospital, Uganda », African Health Sciences, vol. 4, no 1, p. 8, 2004.
VI. G. B. Scott, S. B. Brogly, D. Muenz, A. M. Stek, J. S. Read, et for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team, « Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus », Obstetrics & Gynecology, vol. 129, no 4, p. 621‑628, avr. 2017, doi: 10.1097/AOG.0000000000001929.
VII. S. Kiguli et al., « Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness », BMC Med, vol. 13, no 1, p. 21, déc. 2015, doi: 10.1186/s12916-014-0246-7.
VIII. E. M. Bloch, M. Vermeulen, et E. Murphy, « Blood Transfusion Safety in Africa: A Literature Review of Infectious Disease and Organizational Challenges », Transfusion Medicine Reviews, vol. 26, no 2, p. 164‑180, avr. 2012, doi: 10.1016/j.tmrv.2011.07.006.
IX. A. Fisher, S. Wallis, O. Hassall, R. Martin, et I. Bates, « Collaborations on blood transfusion research in sub‐Saharan Africa: who, what and where », Vox Sang, vol. 115, no 3, p. 221‑232, avr. 2020, doi: 10.1111/vox.12884.
X. E. E. Dogbe et F. Arthur, « Diagnostic accuracy of blood centers in the screening of blood donors for viral markers », Pan Afr Med J, vol. 20, 2015, doi: 10.11604/pamj.2015.20.119.5263.
XI. C. T. Tagny et al., « Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors: TRANSFUSION SAFETY IN FRANCOPHONE AFRICAN COUNTRIES », Transfusion, vol. 52, no 1, p. 134‑143, janv. 2012, doi: 10.1111/j.1537-2995.2011.03391.x.
XII. .W. Fong, « Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges », in Current Trends and Concerns in Infectious Diseases, Cham: Springer International Publishing, 2020, p. 191‑215. doi: 10.1007/978-3-030-36966-8_8.
XIII. C. T. Tagny et D. Mbanya, « Manuel pratique du laboratoire de Transfusion Sanguine dans les Pays en développement », Croix-Rouge de Belgique, p. 141, 2013.
XIV. C. E. Eboumbou Moukoko, F. Ngo Sack, E. G. Essangui Same, M. Mbangue, et L. G. Lehman, « HIV, HBV, HCV and T. palliduminfections among blood donors and Transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon », BMC Hematol, vol. 14, no 1, p. 5, déc. 2014, doi: 10.1186/2052-1839-14-5.
XV. M. Kengne, D. C. Wouado Tsata, T. Ndomgue, et J. Mbekem Nwobegahay, « Prevalence and risk factors of HTLV-1/2 and other blood borne infectious diseases among blood donors in Yaounde Central Hospital, Cameroon », Pan Afr Med J, vol. 30, 2018, doi: 10.11604/pamj.2018.30.125.14802.
XVI. F. Chabrol et al., « Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs », BMJ Open, vol. 9, no 3, p. e025415, mars 2019, doi: 10.1136/bmjopen-2018-025415.
XVII. C. E. Eboumbou Moukoko, F. Ngo Sack, E. G. Essangui Same, M. Mbangue, et L. G. Lehman, « HIV, HBV, HCV and T. palliduminfections among blood donors and Transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon », BMC Hematol, vol. 14, no 1, p. 5, déc. 2014, doi: 10.1186/2052-1839-14-5.
XVIII. C. T. Tagny, A. Ndoumba, S. Laperche, E. Murphy, et D. Mbanya, « Reducing risks of Transfusion-transmitted infections in a resource-limited hospital-based blood bank: the case of the Yaoundé University Teaching Hospital, Cameroon », VOXS, vol. 11, no 2, p. 82‑87, août 2016, doi: 10.1111/voxs.12287.
XIX. World Health Organization, « Screening donated blood for transfusion-transmissible infections : recommendations », World Health Organization, p. 66, 2009, Consulté le: 10 septembre 2022. [En ligne]. Disponible sur:
https://apps.who.int/iris/handle/10665/44202
XX. D. N. Noah, F. A. Andoulo, B. V. M. Essoh, G. N. Ayissi, S. A. F. E. Bagnaka, et M. B. Sida, « Prevalence of HBs Antigen, and HCV and HIV Antibodies in a Young Male Population in Cameroon », OJGas, vol. 05, no 12, p. 185‑190, 2015, doi: 10.4236/ojgas.2015.512028.
XXI. National Institute of Statistics, « Cameroon population-based HIV impact assessment Camphia 2017 », National Institute of Statistics, Cameroon, juill. 2018.
XXII. National Institute of Statistics, « Cameroon Demographic and Health Survey », National Institute of Statistics, Cameroon, Summary Report, 2018.
XXIII. C. Kengne-Nde et al., « Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis », PLoS ONE, vol. 15, no 11, p. e0241999, nov. 2020,
doi: 10.1371/journal.pone.0241999.
XXIV. M. Samje et al., « Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon », Transfusion Clinique et Biologique, vol. 28, no 3, p. 228‑233, août 2021, doi: 10.1016/j.tracli.2021.05.011.
XXV. J. J. N. Noubiap, W. Y. A. Joko, J. R. N. Nansseu, U. G. Tene, et C. Siaka, « Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon », International Journal of Infectious Diseases, vol. 17, no 10, p. e832‑e837, oct. 2013,
doi: 10.1016/j.ijid.2012.12.007.
XXVI. D. Mbanya, M. Sama, et P. Tchounwou, « Current Status of HIV/AIDS in Cameroon: How Effective are Control Strategies? », Int. J. Environ. Res. Public Health, p. 6, 2008.
XXVII. J. Dionne-Odom et al., « Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon », Infectious Diseases in Obstetrics and Gynecology, vol. 2016, p. 1‑8, 2016, doi: 10.1155/2016/4359401.
XXVIII. F. Fouelifack Ymele, B. Keugoung, J. H. Fouedjio, N. Kouam, S. Mendibi, et J. Dongtsa Mabou, « High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings », Journal of Blood Transfusion, vol. 2012, p. 1‑7, oct. 2012, doi: 10.1155/2012/458372.
XXIX. M. L. Koanga Mogtomo, L. P. Kojom Foko, E. V. Assokom Okoubalimba, E. E. Enyegue, et A. R. Ngono Ngane, « High Risk of Transfusion-Transmitted Malaria (TTM) from Student Blood Donors Living in the Town of Douala, Cameroon », J Clin Infect Dis Pract, vol. 01, no 01, 2016, doi: 10.4172/2476-213X.1000108.
XXX. M. Loriette et al., « An experience of hepatitis B control in a rural area in Far North Cameroon », Médecine et Santé Tropicales, vol. 25, no 4, p. 422‑427, oct. 2015, doi: 10.1684/mst.2015.0507.
XXXI. C. N. Funeh et al., « Seroprevalence of hepatitis B virus among people screened at a primary care hospital in Bamenda: a cross-sectional study », p. 8.
XXXII. D. Noah Noah, R. Njouom, A. Bonny, P. Pirsou, J. Meli, et M. B. Sida, « HBs antigene prevalence in blood donors and the risk of transfusion of hepatitis b at the central hospital of yaounde, cameroon », OJGas, vol. 01, no 02, p. 23‑27, 2011, doi: 10.4236/ojgas.2011.12004.
XXXIII. J. J. N. Noubiap, W. Y. A. Joko, J. R. N. Nansseu, U. G. Tene, et C. Siaka, « Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon », International Journal of Infectious Diseases, vol. 17, no 10, p. e832‑e837, oct. 2013,
doi: 10.1016/j.ijid.2012.12.007.
XXXIV. B. Gake et al., « Low seroprevalence of Zika virus in Cameroonian blood donors », The Brazilian Journal of Infectious Diseases, vol. 21, no 4, p. 481‑483, juill. 2017,
doi: 10.1016/j.bjid.2017.03.018.
XXXV. M. I. Matee, P. M. Magesa, et E. F. Lyamuya, « Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania », BMC Public Health, p. 6, 2006.
XXXVI. F. I. Buseri, M. A. Muhibi, et Z. A. Jeremiah, « Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, South-West, Nigeria », Blood Transfusion, 2009, doi: 10.2450/2009.0071-08.
XXXVII. A. Ducancelle et al., « High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North Cameroon », PLoS ONE, vol. 8, no 11, p. e80346, nov. 2013, doi: 10.1371/journal.pone.0080346.
XXXVIII. C. Fritzsche et al., « Hepatitis B and C: neglected diseases among health care workers in Cameroon », Transactions of The Royal Society of Tropical Medicine and Hygiene, p. 158‑64, mars 2013. Consulté le: 21 septembre 2022. [En ligne]. Disponible sur:
https://academic.oup.com/trstmh/article-lookup/doi/10.1093/trstmh/trs087
XXXIX. S. Abdella et al., « Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study », PLoS ONE, vol. 15, no 10, p. e0241086, oct. 2020, doi: 10.1371/journal.pone.0241086.
XL. F. S. Bisetegen, F. B. Bekele, T. A. Ageru, et F. W. Wada, « Transfusion-Transmissible Infections among Voluntary Blood Donors at Wolaita Sodo University Teaching Referral Hospital, South Ethiopia », Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 2016, p. 1‑6, 2016, doi: 10.1155/2016/8254343.
XLI. B. Biadgo, E. Shiferaw, B. Woldu, K. A. Alene, et M. Melku, « Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study », PLoS ONE, vol. 12, no 7, p. e0180416, juill. 2017,
doi: 10.1371/journal.pone.0180416.
XLII. M. Negash, M. Ayalew, D. Geremew, et M. Workineh, « Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia », BMC Infect Dis, vol. 19, no 1, p. 430, déc. 2019, doi: 10.1186/s12879-019-4051-y.
XLIII. E. B. Ahmed, A. A. Essa, B. S. Almugadam, Q. M. Ahmed, et M. M. Hussein, « Transfusion transmitted infections among male blood donors of White Nile State, Sudan: Screening of the current seroprevalence and distribution », BMC Res Notes, vol. 13, no 1, p. 549, déc. 2020, doi: 10.1186/s13104-020-05333-6.
XLIV. A. Mayomo Fohoue, F. Ngo Sack, C. Tchinda Fossi, A. Fossi, et Y. Bassong Olga, « Prévalence des Infections Transmissibles par Transfusion Sanguine chez les Donneurs de Sang à l’Hôpital Central de Yaoundé - Cameroun », Health Science Disease, vol. 20, p. 6, 2019.
XLV. D. M. Doungous et al., « Prévalence de la syphilis chez les donneurs de sang à la Banque du Sang d’Abéché au Tchad », Int. J. Bio. Chem. Sci, vol. 14, no 3, p. 1085‑1092, juin 2020,
doi: 10.4314/ijbcs.v14i3.34.
XLVI. T. Alharazi et al., « Prevalence of Transfusion-Transmitted Infections (HCV, HIV, Syphilis and Malaria) in Blood Donors: A Large-Scale Cross-Sectional Study », Pathogens, vol. 11, no 7, p. 726, juin 2022, doi: 10.3390/pathogens11070726.